For the past 40 years Neonatal research at UCH and UCL has focused on the diagnosis and pathophysiology of perinatal brain injury, and more recently it has been in the international forefront of the evaluation of neuroprotective interventions and the application of magnetic resonance techniques for biomarker discovery and validation.
Professor Neil Marlow's arrival in 2008 helped to grow, in particular, work on preterm brain injury and developmental outcomes making UCL a leading centre for work on longitudinal cohort studies, such as EPICure, and developing the investigation of the preterm brain with imaging and novel neuropsychological strategies.
Since 2003 Professor Nicola Robertson has led the group to major advances in the understanding of therapeutic hypothermia and novel neuroprotective strategies following perinatal hypoxic ischaemia.
Dr Subhabrata Mitra joined the institute in 2016 and is leading advances in neuromonitoring and neuroimaging in neonatal seizures and neonatal encephalopathy. The group’s research focusses on optimising brain monitoring for better understanding of pathophysiological changes and development of early biomarkers following perinatal brain injury.
Research focuses on developing new therapeutic intervention for neonatal lung disease based on his internationally recognised expertise in lung surfactant proteins. This work has been recognised by substantial awards from the Medical Research Council to carry out first in man trials of novel surfactant protein immunotherapy.
UCH Neonatal Services contributes to clinical trials and studies, which are mulicentre - recent studies have included the HTA funded PIPS and two UCL-based FP7 funded studies: NEMO and EVERREST. New studies are currently under consideration.
Long term outcomes for babies born very prematurely or following perinatal asphyxia are improving. We are investigating these long-term effects from epidemiological and neuroscience perspectives grounded on national and local cohort studies.
Our aim is to optimize and refine neuroprotection of the term infant using a translational pre-clinical model of perinatal asphyxia. Our team includes neonatologists, physicists and scientists. We are focus on magnetic resonance, EEG and NIRS biomakers which can be used interchangeably in clinical studies.
Globally, newborn brain injury is the third leading cause of childhood mortality. With partners in Uganda, the UK and Australia we are investigating the aetiology of, and outcomes from newborn brain injury to help prevent future newborn detahs and long-term disability.
The group is investigating the impact of seizures on newborn infant on a Wellcome Trust funded study in collaboration with Biomedical Optics Research Laboratory in UCL and infant research centre in University College Cork.
We use a multimodal platform of advanced optical neuromonitoring, systemic physiological data, video EEG, magnetic resonance imaging and spectroscopy to develop early biomarkers of perinatal brain injury for assessment of injury and outcome prediction.
We are a unique team of neonatologists, neuroscientists, clinical neurophysiologists and statistical scientists who are working together to discover how newborn infants process touch, pressure and pain.
Explore the lists of research students within our Research Department of Neonatology and visit their profiles.